Clinical Outcomes of Transcutaneous Tibial Nerve Stimulation: Face-to-Face Versus Telehealth Tuition
International Urogynecology Journal · 2025
DOI: 10.1007/s00192-025-06475-6 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift International Urogynecology Journal, 2025. Verfasst von Tess Nagy und 5 weiteren Autor:innen. Beteiligte Einrichtung: Pelvic Floor Unit, St. George Hospital, Gray St., Kogarah, NSW, 2217, Australia. tess.carruthers@health.nsw.gov.au. Hauptthemen laut MEDLINE: Transcutaneous Electric Nerve Stimulation, Urinary Bladder, Overactive. Die Arbeit nennt 14 Literaturangaben.
Themen: Digitalisierung in der Pflege
Abstract (Originalsprache)
INTRODUCTION AND HYPOTHESIS: Transcutaneous tibial nerve stimulation (TTNS) is used to treat overactive bladder (OAB) syndrome. We hypothesized that TTNS instruction delivered via telehealth (TH) would be as effective as face-to-face (FtF) instruction in improving OAB symptoms. METHODS: In this prospective cohort study, 99 women with OAB self-selected FtF (n = 79) or TH (n = 20) instruction for TTNS setup. Groups received standardized education on device placement and usage. Primary outcome was the between-group comparison of change in International Consultation on Incontinence Questionnaire (ICIQ-SF) scores at 3 and 12 months. Secondary outcomes included between-group comparisons of Patient Global Impression of Improvement (PGI-I) score at 3 months and treatment persistence at 12 months. Between-group differences were analyzed using Student's t tests. RESULTS: At 3 months, FtF and TH groups showed mean ICIQ-SF score reductions of 2.3 ± 1.8 and 1.9 ± 1.6 points respectively (between-group difference 0.4 points; 95% CI -1.79, 2.59; p = 0.60). PGI-I scores indicated improvement in 48.1% of FtF and 50.0% of TH participants. At 12 months, treatment persistence was 60.8% for FtF and 55.0% for TH groups. Among continued treatment responders, sustained improvement was observed, with mean ICIQ-SF reductions of 3.6 ± 2.4 points (FtF) and 4.0 ± 2.6 points (TH) from baseline (p = 0.48). Progression to third-line therapies was comparable between groups (FtF 24.0%, TH 25.0%). CONCLUSIONS: Telehealth shows promise as an effective method for initiating TTNS treatment for OAB, providing comparable outcomes with FtF instruction. The approximate 50% response rate and sustained benefits among responders support TTNS as a viable treatment. Findings support broader implementation of TH TTNS instruction, potentially improving treatment access for suitable patients.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Pelvic Floor Unit, St. George Hospital, Gray St., Kogarah, NSW, 2217, Australia. tess.carruthers@health.nsw.gov.au.
- Pelvic Floor Unit, St. George Hospital, Gray St., Kogarah, NSW, 2217, Australia.
- University of New South Wales, Sydney, Australia.
Zitieren
APA
Nagy, T., Allen, W., Parkin, K., Karantanis, E., Moore, K. H., & Chen, Z. (2025). Clinical Outcomes of Transcutaneous Tibial Nerve Stimulation: Face-to-Face Versus Telehealth Tuition. International Urogynecology Journal. https://doi.org/10.1007/s00192-025-06475-6
Vancouver
Nagy T, Allen W, Parkin K, Karantanis E, Moore KH, Chen Z. Clinical Outcomes of Transcutaneous Tibial Nerve Stimulation: Face-to-Face Versus Telehealth Tuition. International Urogynecology Journal. 2025. doi:10.1007/s00192-025-06475-6
BibTeX
@article{Nagy2025,
author = {Nagy, Tess and Allen, Wendy and Parkin, Katrina and Karantanis, Emmanuel and Moore, Kate H and Chen, Zhuoran},
title = {Clinical Outcomes of Transcutaneous Tibial Nerve Stimulation: Face-to-Face Versus Telehealth Tuition},
journal = {International Urogynecology Journal},
year = {2025},
doi = {10.1007/s00192-025-06475-6}
}
EUVIMED